Tag: Venetoclax

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Venetoclax

SLS009 Earns FDA Fast Track Designation for R/R PTCL - Targeted Oncology

Added to Collection on: 2023-10-30 14:06:11

Tags for this article:

Orphan drugs
Antineoplastic drugs
Breakthrough therapy
Benzamides
Sulfonamides
Venetoclax
Peripheral T-cell lymphoma not otherwise specified
Subcutaneous T-cell lymphoma

Click the tags to see associated articles and topics

View Article Details
First-Time Treated CLL Pirtobrutinib Obinutuzumab - HealthTree for Chronic Lymphocytic Leukemia

Added to Collection on: 2024-04-17 16:35:16

Tags for this article:

Orphan drugs
Ibrutinib
Venetoclax
Acalabrutinib
Bruton's tyrosine kinase
Zanubrutinib
Obinutuzumab
Bcl-2
Chronic lymphocytic leukemia
Richter's transformation
Inhye Ahn
CLL Labs

Click the tags to see associated articles and topics

View Article Details
FDA Grants Fast Track Designation to ICT01 Plus Azacitidine and Venetoclax in AML

Added to Collection on: 2024-09-18 22:15:18

Tags for this article:

Orphan drugs
Antineoplastic drugs
Benzamides
Chloroarenes
Sulfonamides
Venetoclax
Acute myeloid leukemia
7+3
Leukemia
Vadastuximab talirine
Lintuzumab

Click the tags to see associated articles and topics

View Article Details
Ellipses Pharma publishes data from phase 1/2 clinical trial of EP0042

Added to Collection on: 2024-12-13 18:35:40

Tags for this article:

Orphan drugs
Tyrosine kinase receptors
Benzamides
Venetoclax
CD135
Acute myeloid leukemia
Lestaurtinib
Shutterstock

Click the tags to see associated articles and topics

View Article Details
Adding Venetoclax to Decitabine-Cedazuridine Improves Response in MDS Subgroups

Added to Collection on: 2025-04-25 22:03:48

Tags for this article:

Orphan drugs
Otsuka Pharmaceutical
Nucleosides
Lactams
Triazines
Decitabine/cedazuridine
Myelodysplastic syndrome
Decitabine
Chronic myelomonocytic leukemia
Venetoclax
Hypomethylating agent
Azacitidine

Click the tags to see associated articles and topics

View Article Details
AbbVie (ABBV) Announces Unsuccessful Phase 3 Trial for Blood Cancer Drug

Added to Collection on: 2025-06-17 22:39:39

Tags for this article:

Orphan drugs
Benzamides
Venetoclax
AbbVie
Azacitidine
TipRanks
Acute myeloid leukemia
Myelodysplastic syndrome
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
Genentech Provides Update on Phase III Verona Study - Pipelinereview

Added to Collection on: 2025-06-17 13:30:27

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lactams
Nucleosides
Triazines
Venetoclax
Genentech
AbbVie
Bcl-2
Decitabine
Azacitidine
Acute myeloid leukemia
SOUTH SAN FRANCISCO

Click the tags to see associated articles and topics

View Article Details
Novel Agents Outperform Traditional Therapies in Older Adults With CLL

Added to Collection on: 2025-08-01 13:45:09

Tags for this article:

Orphan drugs
Chronic lymphocytic leukemia
Venetoclax
Leukemia
Survival rate
Richter's transformation

Click the tags to see associated articles and topics

View Article Details
Optimizing BTK Inhibitor Therapy Across B-Cell Malignancies - Oncology Nurse Advisor

Added to Collection on: 2025-08-08 13:34:19

Tags for this article:

Orphan drugs
Tyrosine kinase inhibitors
Piperidines
Antineoplastic drugs
Peripheral membrane proteins
Bruton's tyrosine kinase
Ibrutinib
Chronic lymphocytic leukemia
Zanubrutinib
Acalabrutinib
Venetoclax
Obinutuzumab
Amy L. Goodrich

Click the tags to see associated articles and topics

View Article Details
Ryvu Therapeutics Reports 2025 Half-Year Financial Results

Added to Collection on: 2025-09-18 17:17:02

Tags for this article:

Orphan drugs
Medical research
BioNTech
Acute myeloid leukemia
Ruxolitinib
Venetoclax
Pelabresib
Ryvu Therapeutics
Poland

Click the tags to see associated articles and topics

View Article Details
Book a Demo